Sublingual dmLT

double-mutant heat-labile toxin (dmLT) · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual dmLT, covering 2019-01-28 to 2019-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Sublingual dmLT for ETEC [Phase 1]